| Literature DB >> 27437712 |
Igor Magalhães1, Martim Bottaro1, João R Freitas2, Jake Carmo1, João P C Matheus2, Rodrigo L Carregaro1,2,3.
Abstract
OBJECTIVES: The aim of this study was to investigate the effects of continuous (48-hour) use of Kinesiotaping (KT) on functional and proprioceptive performance in healthy, physically active men.Entities:
Mesh:
Year: 2016 PMID: 27437712 PMCID: PMC4946837 DOI: 10.1590/bjpt-rbf.2014.0151
Source DB: PubMed Journal: Braz J Phys Ther ISSN: 1413-3555 Impact factor: 3.377
Figure 1Study flowchart.
Figure 2Illustration of the tape, after application.
Figure 3Illustration of the initial position of the hop test (A) and vertical jump test (B).
Participants’ physical characteristics. Data are presented as mean (standard deviation).
|
|
| |
|---|---|---|
|
| 20.91 (2.23) | 21.80 (2.22) |
|
| 78.78 (15.06) | 83.17 (9.56) |
|
| 1.74 (0.06) | 1.78 (0.04) |
|
| 25.97 (5.48) | 26.23 (2.48) |
BMI: Body Mass Index; KG: Kinesiotaping group; CG: Control group.
Values of the single hop test (SHT), triple hop test (THT), vertical jump height, power, and rate of force development (RFD) for the Kinesiotaping group (KG) and control group (CG). Data are presented as mean (standard deviation).
|
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
| KG | 99.6 (11.9) | 101.6 (12.4) | –2.0 [–7.5; 3.4] | 0.2 | 100.2 (12.0) | –0.6 [–6.8; 5.5] | 0.0 | 100.5 (11.6) | –0.9 [–7.5; 5.5] | 0.1 |
| CG | 98.7 (10.6) | 96.8 (12.3) | 1.8 [–4.9; 8.7] | 0.2 | 99.4 (10.0) | –0.6 [–6.5; 5.3] | 0.1 | 98.4 (9.0) | 0.3 [–5.9; 6.6] | 0.0 |
|
| ||||||||||
| KG | 282.1 (44.2) | 278.1 (44.2) | 3.9 [–10.6; 18.5] | 0.1 | 276.7 (46.8) | 5.4 [–8.2; 19.1] | 0.1 | 285.2 (47.7) | –.0 [–13.1; 6.9] | 0.1 |
| CG | 283.5 (37.0) | 290.6 (38.5) | –7.0 [–22.0; 8.0] | 0.2 | 295.6 (32.2) | –12.0 [-29.8; 5.7] | 0.3 | 287.8 (38.5) | –4.2 [–20.9; 12.4] | 0.1 |
|
| ||||||||||
| KG | 4.5 (0.8) | 4.1 (0.5) | 0.3 [–0.7; 1.4] | 0.5 | 3.9 (0.8) | 0.6 [–0.6; 1.9] | 0.7 | 4.3 (0.8) | 0.2 [–1.0; 1.4] | 0.2 |
| CG | 4.8 (2.0) | 4.7 (1.8) | 0.6 [–1.5; 1.6] | 0.0 | 4.8 (1.7) | 0.01 [–1.5; 1.5] | 0.0 | 4.3 (1.2) | 0.4 [–1.7; 2.6] | 0.2 |
|
| ||||||||||
| KG | 0.04 (0.03) | 0.06 (0.03) | –0.02 [–0.07; 0.03] | 0.7 | 0.06 (0.03) | –0.02 [–0.07; 0.02] | 0.7 | 0.05 (0.03) | –0.01 [–0.05; 0.03] | 0.3 |
| CG | 0.05 (0.03) | 0.07 (0.05) | –0.02 [–0.1; 0.06] | 0.7 | 0.06 (0.07) | –0.01 [–0.12; 0.09] | 0.3 | 0.08 (0.09) | –0.02 [–0.17; 0.12] | 1.0 |
|
| ||||||||||
| KG | 615.6 (169.3) | 615.5 (128.6) | 0.06 [–108.4; 108.5] | 0.0 | 610.4 (142.6) | 5.1 [–106.3; 116.6] | 0.0 | 609.1 (126.7) | 6.4 [–90.8; 103.7] | 0.0 |
| CG | 626.5 (76.4) | 664.1 (88.8) | –37.5 [–135.4; 60.4] | 0.5 | 662.7 (66.7) | –36.1 [–160.4; 88.1] | 0.5 | 627.7 (99.3) | –1.1 [–122.8; 120.5] | 0.0 |
MD: Mean Difference; 95% CI: 95% Confidence Interval; ES: Effect size; BL: Baseline; T0: Immediate post-tape application; T24: 24h post-tape application; T48: 48h post-tape application; SHT, THT and Jump height were normalized by subject's height. RFD was normalized by subject's mass.